Sensus Healthcare Announces FDA Market Clearance for Sensus Healthcare’s New Sculptura™ Radiation Oncology System

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted market clearance for the Company’s groundbreaking Sculptura™ radiation oncology system. A single treatment during surgery, Sculptura™ can provide cancer patients and physicians a single radiation treatment at the point of surgery.

Read the full press release here.

Share to:

Contact Us

Fill out the form below to find out more!